Cancer care in Switzerland

Switzerland is known for having one of the best healthcare systems in the world. The decentralised structure favours an almost unconstrained choice of providers and a high availability and accessibility of healthcare services. However, this comes at a significant cost: health expenditure in Switzerland is higher than in most Organisation for Economic Co-operation and Development (OECD) countries. This is why international organisations like the World Health Organization and OECD have pointed out that Switzerland’s main challenges lie in becoming more cost-effective.1 Indeed, with the second highest healthcare spending in the world2 and an above-average investment in cancer care of more than 6%,3 Switzerland produces lower health outcomes per money spent compared with other countries.4

Every year, more than 40,000 Swiss citizens are diagnosed with cancer.5 While incidence rates for cancer have remained constant since 1980, mortality rates have dropped by more than 30%. This achievement was possible thanks to medical advances in diagnostic technology, medicines and care.6 Nonetheless, the diagnosis for people with cancer still comes with a high burden for patients as well as their environment. There are countless opportunities across Switzerland to make cancer care more efficient and more sustainable. In particular, cancer care should become more patient-centred, focusing on patient needs and patient-reported outcomes. This is what All.Can Switzerland intends to do.

All.Can Switzerland initiative

All.Can Switzerland launched in early 2018 with a handful of interested stakeholders. Throughout the year, its first projects were initiated. In November 2019, All.Can Switzerland officially launched as a Non-profit organisation with an event at the University of Zurich with nearly 100 stakeholders of the Swiss healthcare and policy system present.

All.Can Switzerland’s vision is to develop solutions for sustainable cancer care, with a strong focus on improving patient outcomes. All.Can Switzerland wants to achieve this through an open dialogue and a broad collaboration with all interested stakeholders sharing the same vision.

Therefore, we are continuously expanding our membership base and are always looking for interested stakeholders and possible project partners. Interested in All.Can Switzerland? Please get in touch with us: switzerland@all-can.org

Visit the All.Can Switzerland website here.

References

  1. OECD. 2011. OECD Reviews of Health Systems – Switzerland, p. 9. Available here: http://www.oecd.org/switzerland/oecdreviewsofhealthsystems-switzerland.htm [accessed: May 2018]
  2. OECD. 2018. Health spending. Available here: https://data.oecd.org/chart/5b8O [accessed: May 2018]
  3. Wieser et al. 2014. Die Kosten der nichtübertragbaren Krankheiten in der Schweiz, Schlussbericht, p. 52. Available here: http://bit.ly/zhaw14 [accessed: August 2018]
  4. OECD. 2018 Available here: http://stats.oecd.org/ [accessed: May 2018]
  5. Heusser et al. 2017. Krebs in der Schweiz, Zahlen Weiterentwicklung der Krebsregistrierung und Folgen, in: Onkologe, 23:588-596. Available here: http://dx.doi.org/10.1007/s00761-017-0252-4
  6. Federal Office of Statistics/NICER. 2017. Schweizer Krebsbericht 2015. Available here: http://bit.ly/Krebsbericht [accessed: August 2018]

All.Can Switzerland welcomes new Member

All.Can Switzerland is pleased to welcome Novartis Switzerland as a new member of All.Can Switzerland this year. The oncology unit Novartis Oncology will contribute its expertise and network from the field of cancer treatments in the future to achieve the goals of All.Can Switzerland: improving…

Read more

Contact

www.allcan-schweiz.ch

Board

Jan Depta

Oliver Kessler

Lucerne University of Applied Sciences and Arts, Competence Center for Public and Nonprofit Management

Professor Brigitte Tag

Dean, Faculty of Law, Chair for Criminal and Medical Law, University of Zurich

Miriam Döbeli

Colontown

Professor Bettina Borisch, MD, MPH, FRCPath

Institute of Global Health, University of Geneva

Henrik Asmussen

General Manager, Amgen

Ans Heirman

Managing Director MSD Switzerland

Christophe Griolet

Gilead Sciences Switzerland Sàrl

Remo Gujer

Bristol Myers Squibb

Steering Committee

Isabel Baur

University of Zurich, Competence Center for Medical Ethics and Law Helvetiae

Nicole Schlumberger

Bristol Myers Squibb

Sina Staudinger

Felix Niggli

Stiftung Kinderkrebsforschung Schweiz

Nuriye Vanggaard

Gilead Switzerland

Secretariat

Sara Käch

Sensor Advice

All.Can Switzerland welcomes new Member

All.Can Switzerland is pleased to welcome Novartis Switzerland as a new member of All.Can Switzerland this year. The oncology unit Novartis Oncology will contribute its expertise and network from the…

All.Can Switzerland – Updates

New members All.Can Switzerland is very happy to welcome two new members to All.Can Switzerland this fall: Sororis Switzerland (Sororis Schweiz) is an organization of self-affected breast cancer patients based…

All.Can Switzerland welcomes Childhood Cancer Research Foundation Switzerland as new member

All. Can Switzerland is very happy to welcome the Childhood Cancer Research Foundation Switzerland (Stiftung Kinderkrebsforschung Schweiz) as a new member. The foundation exclusively supports research in the area of…

All.Can Switzerland Annual Report

In our first annual report, we talk about the vision of All.Can Switzerland and look back at its foundation as an association in 2019. We also take a look at…

All.Can Switzerland Updates – March 2021

Member Update Gilead Switzerland new member We are very happy to welcome Gilead Sciences Switzerland Sàrl as a new member of All.Can Switzerland. Gilead joined us in March 2021 and…

All.Can Switzerland – Activity Update

Towards Novel Reimbursement models for Expensive Advanced Therapy Medicinal Products (AMTPs): In the “Fresh Ideas for Cancer Care” project, launched in 2019 as a doctorates program at the University of…

All.Can Switzerland – Update

New Project: Nurse-led clinicIn 2020, All.Can Switzerland decided to support a new project focusing on the establishing of a «Nurse-led clinic» in an outpatient oncology network in the canton of…

All.Can Switzerland initiative officially launches as a non-profit organisation

All.Can Switzerland has officially launched as a non-profit organisation with an event at the University of Zurich.

Switzerland becomes latest country to launch national All.Can initiative

All.Can Switzerland has officially launched, joining other countries across Europe, Australia and Canada.

Past events

All.Can Switzerland steering committee meeting – 23 Jan 2019

23 January 2019

Zurich

Meeting of the All.Can Switzerland steering committee

All.Can Switzerland steering committee meeting – 20 Mar 2019

20 March 2019

Zurich

Meeting of the All.Can Switzerland steering committee

All.Can Switzerland steering committee meeting – 28 May 2019

28 May 2019

Zurich

Meeting of the All.Can Switzerland steering committee

All.Can Switzerland steering committee meeting – 9 July 2019

9 July 2019

Zurich

Meeting of the All.Can Switzerland steering committee

All.Can Switzerland steering committee meeting – 23 Sept 2019

23 September 2019

Zurich

Meeting of the All.Can Switzerland steering committee

All.Can Switzerland steering committee meeting – 12 Nov 2019

12 November 2019

Zurich

Meeting of the All.Can Switzerland steering committee

All.Can Switzerland steering committee meeting – 31 Jan 2020

31 January 2020

Meeting of the All.Can Switzerland steering committee

All.Can Switzerland steering committee meeting – 12 May 2020

12 May 2020

Meeting of the All.Can Switzerland steering committee

All.Can Switzerland board meeting – 1 July 2020

1 July 2020

Meeting of the All.Can Switzerland Board

All.Can Switzerland steering committee meeting – 23 Aug 2020

25 August 2020

Meeting of the All.Can Switzerland steering committee

All.Can Switzerland steering committee meeting – 17 Nov 2020

17 November 2020

Meeting of the All.Can Switzerland steering committee

All.Can Switzerland an introduction

English version:

 

German version:

Interview with Isabel Baur about the ‘Fresh Ideas for Cancer Care’ project

Isabel Baur, University of Zurich, Competence Center for Medical Ethics and Law Helvetiae, talks about the ‘fresh ideas for cancer care’ project, which unites PhD students with stakeholders from various sectors to develop innovations in cancer care.

English version:

German version:

Interview with Oliver Kessler about the project ‘Optimising cancer care in central Switzerland’

Oliver Kessler, Lucerne University of Applied Sciences and Arts, Competence Center for Public and Nonprofit Management, talks about the All.Can Switzerland project focusing on optimising cancer care in central Switzerland.

English version:

German version:

Disclaimer:

The All.Can initiative is made up of leading representatives of patient organisations, policymakers, healthcare professionals, science and industry. All the publications produced under the initiative reflect the consensus of All.Can members who have full editorial control. The All.Can initiative in Switzerland is supported (financially and/or in kind) by Amgen, Bristol Myers Squibb, MSD, Lucerne University of Applied Sciences and Arts, and University of Zurich.